Ki Hwan Kim

Ki Hwan Kim

Auto-generated profile, based on publicly available information

Ki Hwan Kim

Lunit, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
JAJong Seok Ahn
Jong Seok Ahn
SSSangwon Shin
Sangwon Shin
SYSu-A Yang
Su-A Yang
EPEun Kyung Park
Eun Kyung Park
KKKi Hwan Kim
Ki Hwan Kim
SKSeokhwi Kim
Seokhwi Kim
Ahn JS, et al. J Breast Cancer. 2023 Oct;26:e45. https://doi.org/10.4048/jbc.2023.26.e45

1 December 2019 in Radiology
Verified
Journal Article
Open access
EHEui Jin Hwang
Eui Jin Hwang
Ju Gang NamJu Gang Nam
Ju Gang Nam
WLWoo Hyeon Lim
Woo Hyeon Lim
SPSae Jin Park
Sae Jin Park
YJYun Soo Jeong
Yun Soo Jeong
CPChang Park
Chang Park
Use of a commercially available deep learning algorithm for evaluating chest radiographs resulted in identification of clinically relevant abnormalities on emergency department radiographs and impr... BackgroundThe performance of a deep learning (DL) algorithm should be validated in actual clinical situations, before its clinical implementation.PurposeTo evaluate the performance of a DL algorith...

1 January 2022 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
JLJeong Hoon Lee
Jeong Hoon Lee
KKKi Hwan Kim
Ki Hwan Kim
ELEun Hye Lee
Eun Hye Lee
JAJong Seok Ahn
Jong Seok Ahn
JRJung Kyu Ryu
Jung Kyu Ryu
HCHye Young Choi
Hye Young Choi
Lee JH, et al. Korean J Radiol. 2022 May;23(5):505-516. https://doi.org/10.3348/kjr.2021.0476

22 April 2024 in Breast Cancer Research
Verified
Journal Article
Open access
PDF file
MKMi-ri Kwon
Mi-ri Kwon
YCYoosoo Chang
Yoosoo Chang
SHSoo-Youn Ham
Soo-Youn Ham
YCYoosun Cho
Yoosun Cho
EKEun Young Kim
Eun Young Kim
SRSeungho Ryu
Seungho Ryu
Background: Artificial intelligence (AI) algorithms for the independent assessment of screening mammograms have not been well established in a large screening cohort of Asian women. We compared the performance of screening digital mammography considering breast density, between radiologists and AI standalone detection among Korean women. Methods: We retrospectively included 89,855 Korean women who underwent their initial screening digital mammography from 2009 to 2020. Breast cancer within 12 months of the screening mammography was the reference standard, according to the National Cancer Registry. Lunit software was used to determine the probability of malignancy scores, with a cutoff of 10% for breast cancer detection. The AI’s performance was compared with that of the final Breast Imaging Reporting and Data System category, as recorded by breast radiologists. Breast density was classified into four categories (A–D) based on the radiologist and AI-based assessments. The performance metrics (cancer detection rate [CDR], sensitivity, specificity, positive predictive value [PPV], recall rate, and area under the receiver operating characteristic curve [AUC]) were compared across breast density categories. Results: Mean participant age was 43.5 ± 8.7 years; 143 breast cancer cases were identified within 12 months. The CDRs (1.1/1000 examination) and sensitivity values showed no significant differences between radiologist and AI-based results (69.9% [95% confidence interval [CI], 61.7–77.3] vs. 67.1% [95% CI, 58.8–74.8]). However, the AI algorithm showed better specificity (93.0% [95% CI, 92.9–93.2] vs. 77.6% [95% CI, 61.7–77.9]), PPV (1.5% [95% CI, 1.2–1.9] vs. 0.5% [95% CI, 0.4–0.6]), recall rate (7.1% [95% CI, 6.9–7.2] vs. 22.5% [95% CI, 22.2–22.7]), and AUC values (0.8 [95% CI, 0.76–0.84] vs. 0.74 [95% CI, 0.7–0.78]) (all P < 0.05). Radiologist and AI-based results showed the best performance in the non-dense category; the CDR and sensitivity were higher for radiologists in the heterogeneously dense category (P = 0.059). However, the specificity, PPV, and recall rate consistently favored AI-based results across all categories, including the extremely dense category. Conclusions: AI-based software showed slightly lower sensitivity, although the difference was not statistically significant. However, it outperformed radiologists in recall rate, specificity, PPV, and AUC, with disparities most prominent in extremely dense breast tissue.

1 January 2022 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
YCYun-Woo Chang
Yun-Woo Chang
JAJin Kyung An
Jin Kyung An
NCNami Choi
Nami Choi
KKKyung Hee Ko
Kyung Hee Ko
KKKi Hwan Kim
Ki Hwan Kim
JRJung Kyu Ryu
Jung Kyu Ryu
Chang YW, et al. J Breast Cancer. 2022 Jan;25:e4. https://doi.org/10.4048/jbc.2022.25.e4

7 June 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
EPEun Kyung Park
Eun Kyung Park
HLHyeonsoo Lee
Hyeonsoo Lee
MKMinjeong Kim
Minjeong Kim
TKTaesoo Kim
Taesoo Kim
JKJunha Kim
Junha Kim
SRSeungho Ryu
Seungho Ryu
The purposes of this study were to develop an artificial intelligence (AI) model for future breast cancer risk prediction based on mammographic images, investigate the feasibility of the AI model, and compare the AI model, clinical statistical risk models, and Mirai, a state of-the art deep learning algorithm based on screening mammograms for 1–5-year breast cancer risk prediction. We trained and developed a deep learning model using a total of 36,995 serial mammographic examinations from 21,438 women (cancer-enriched mammograms, 17.5%). To determine the feasibility of the AI prediction model, mammograms and detailed clinical information were collected. C-indices and area under the receiver operating characteristic curves (AUCs) for 1–5-year outcomes were obtained. We compared the AUCs of our AI prediction model, Mirai, and clinical statistical risk models, including the Tyrer–Cuzick (TC) model and Gail model, using DeLong’s test. A total of 16,894 mammograms were independently collected for external validation, of which 4002 were followed by a cancer diagnosis within 5 years. Our AI prediction model obtained a C-index of 0.76, with AUCs of 0.90, 0.84, 0.81, 0.78, and 0.81, to predict the 1–5-year risks. Our AI prediction model showed significantly higher AUCs than those of the TC model (AUC: 0.57; p < 0.001) and Gail model (AUC: 0.52; p < 0.001), and achieved similar performance to Mirai. The deep learning AI model using mammograms and AI-powered imaging biomarkers has substantial potential to advance accurate breast cancer risk prediction.